NEW YORK (GenomeWeb) – Veracyte reported after the close of the market on Wednesday that its first quarter earnings rose 21 percent year over year.

For the three months ended March 31, the company reported revenues of $16.4 million, up from $13.6 million a year earlier, but missing the average analyst estimate for revenues of $17.7 million.

Veracyte said volume of its Afirma Gene Expression Classifier test rose 9 percent during Q1 to 5,834 tests.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

In Science this week: environmental DNA can help in studies of marine animals, and more.